"The Genedata Profiler platform is used productively in a validated environment and is helping to democratize access to integrated data in the translational research and clinical settings." - Hisham Hamadeh, Ph.D., Vice President, Global Head of Data Sciences, at Genmab.
"Working closely with Genedata, we have generated a digital biomarker research platform that will enable our scientists to better utilize clinical and translational data to generate innovative ideas for new biomarkers and drug targets" - Joern Peter Halle, Head of Immuno-oncology and External Innovation at Merck.
"We chose Genedata Profiler because it is the end-to-end enterprise software able to harmonize dispersed data analysis pipelines, enhancing our capacity to analyze large amounts of high-dimensional ‘omics data emerging from our rapidly growing number of translational and clinical research projects" - Kimio Terao, Department Manager of Clinical Pharmacology at Chugai.
"We are pleased to have found a reliable partner who provided us with expert knowledge in big multi-omics data analysis to accelerate our search for precision biomarkers to prognosticate disease course and to guide early and effective personalized treatment decisions" - Andrés Hurtado-Lorenzo, Ph.D., Senior Director of Translational Research at the Crohn’s & Colitis Foundation.
"As we expect our clinical and pre-clinical programs and pipeline to continue to grow, we look forward to utilizing Genedata Profiler and Genedata Managed IT Services to assist us in our mission to develop safe, targeted, effective therapeutics for cancer patients" - John de Kruif, Ph.D., Chief Technology Officer of Merus.
"To support our vision of transforming cancer treatment, we are excited to implement the Genedata Biopharma Platform as a central integrated data backbone to streamline the capture, integration, democratization, and analysis of increasingly complex and diverse data types across Genmab’s discovery and clinical workflows" - Hisham Hamadeh, Ph.D., Vice President, Global Head of Data Sciences, at Genmab.